Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
المؤلفون المشاركون
Buchbinder, Rachelle
March, L.
Fletcher, Ashley
Lassere, Marissa
Hill, Catherine
Carroll, Graeme
Barrett, Claire
المصدر
International Journal of Rheumatology
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-9، 9ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-06-05
دولة النشر
مصر
عدد الصفحات
9
التخصصات الرئيسية
الملخص EN
Objectives.
To describe oral complementary medicine (CM) use in people with inflammatory arthritis, associations with use, and changes in use over time.
Methods.
Demographic, clinical, and patient-reported outcome data from 5,630 participants with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), and juvenile idiopathic arthritis (JIA) were extracted from the Australian Rheumatology Association Database (ARAD), a national observational database.
CM use at entry into ARAD was ascertained for participants recruited between 2002 and 2018.
CM was categorised according to the NIH/Cochrane schema (fatty acids, herbs, or supplements).
Logistic regression was used to assess associations between demographic characteristics and CM use.
Change in CM use between 2006 and 2016 was investigated using a nonparametric test for trend of rate by year.
Results.
2,156 (38.3%) ARAD participants were taking CM at enrolment (RA: 1,502/3,960 (37.9%), AS: 281/736 (38.2%), PsA: 334/749 (44.6%), and JIA: 39/185 (21.1%)).
CM use was more prevalent in women (OR 1.3; 95% CI: 1.13-1.50), those with tertiary education (OR 1.32; 95% CI: 1.13-1.55), private health insurance (OR 1.26; (95% CI: 1.10-1.44), drinking alcohol sometimes (OR 1.22; 95% CI: 1.05-1.43), poorer function (HAQ) (OR 1.13; 95% CI: 1.02-1.24), use of NSAID (OR 1.32; 95% CI 1.17-1.50), weak (OR 1.21; 95% CI 1.05-1.41) but not strong opioids, and less prevalent in current smokers (OR 0.76; 95%: CI 0.63-0.91).
CM use was not associated with pain, disease activity, or quality of life.
The most common CMs were fish oils (N=1,489 users) followed by glucosamine (N=605).
Both declined in use over time between 2006 and 2016 (27.5% to 21.4%, trend p=0.85 and 15.5% to 6.4%, trend p<0.01), respectively.
Conclusion.
Oral CM use is common among Australians with inflammatory arthritis.
Its use is greater among women and those with tertiary education.
Fish oil and glucosamine, the most common CMs, both declined in use over time.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Fletcher, Ashley& Lassere, Marissa& March, L.& Hill, Catherine& Carroll, Graeme& Barrett, Claire…[et al.]. 2020. Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis. International Journal of Rheumatology،Vol. 2020, no. 2020, pp.1-9.
https://search.emarefa.net/detail/BIM-1173984
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Fletcher, Ashley…[et al.]. Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis. International Journal of Rheumatology No. 2020 (2020), pp.1-9.
https://search.emarefa.net/detail/BIM-1173984
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Fletcher, Ashley& Lassere, Marissa& March, L.& Hill, Catherine& Carroll, Graeme& Barrett, Claire…[et al.]. Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis. International Journal of Rheumatology. 2020. Vol. 2020, no. 2020, pp.1-9.
https://search.emarefa.net/detail/BIM-1173984
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1173984
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر